TY - JOUR
T1 - Maternal antibody reactivity to lymphocytes of offspring with autism
AU - Bressler, Joseph P.
AU - Gillin, Pam K.
AU - O'Driscoll, Cliona
AU - Kiihl, Samara
AU - Solomon, Megan
AU - Zimmerman, Andrew W.
N1 - Funding Information:
The authors thank the families who participated in the study, including the parents, their children with autism, and unaffected siblings. This study was funded by the Hussman Foundation . The authors also thank Christina M. Morris, MS, and Harvey S. Singer, MD, for contributing data on maternal antibodies.
PY - 2012/11
Y1 - 2012/11
N2 - The study examined whether maternal serum antibodies from mothers of autistic children preferentially bind to lymphocytes of their autistic children compared with unaffected siblings. In a previous study, maternal serum antibodies from mothers mediated cytotoxicity with complement to lymphocytes of their autistic children. Here, maternal serum antibody binding was examined by flow cytometry. We compared levels of mothers' serum binding against peripheral blood monocytes of their autistic children vs unaffected siblings. Because the level of binding to peripheral blood monocytes could be low, binding was examined in specific lymphocyte subpopulations. In 19 samples, the mean level of maternal serum immunoglobulin G binding to CD4 and CD8 T cells, B cells, natural killer cells, and macrophages was not significantly different from the mean level of binding to unaffected siblings. The percentages of different subpopulations were not significantly different between autistic children and unaffected siblings, although a trend (P < 0.1) emerged, i.e., autistic children displayed a higher percentage of natural killer cells and a lower percentage of B cells. These findings cast doubt on a direct effect of maternal antibodies, but do not preclude potential intrauterine pathogenic immune mechanisms in autism.
AB - The study examined whether maternal serum antibodies from mothers of autistic children preferentially bind to lymphocytes of their autistic children compared with unaffected siblings. In a previous study, maternal serum antibodies from mothers mediated cytotoxicity with complement to lymphocytes of their autistic children. Here, maternal serum antibody binding was examined by flow cytometry. We compared levels of mothers' serum binding against peripheral blood monocytes of their autistic children vs unaffected siblings. Because the level of binding to peripheral blood monocytes could be low, binding was examined in specific lymphocyte subpopulations. In 19 samples, the mean level of maternal serum immunoglobulin G binding to CD4 and CD8 T cells, B cells, natural killer cells, and macrophages was not significantly different from the mean level of binding to unaffected siblings. The percentages of different subpopulations were not significantly different between autistic children and unaffected siblings, although a trend (P < 0.1) emerged, i.e., autistic children displayed a higher percentage of natural killer cells and a lower percentage of B cells. These findings cast doubt on a direct effect of maternal antibodies, but do not preclude potential intrauterine pathogenic immune mechanisms in autism.
UR - http://www.scopus.com/inward/record.url?scp=84867288670&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867288670&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2012.06.017
DO - 10.1016/j.pediatrneurol.2012.06.017
M3 - Article
C2 - 23044014
AN - SCOPUS:84867288670
SN - 0887-8994
VL - 47
SP - 337
EP - 340
JO - Pediatric Neurology
JF - Pediatric Neurology
IS - 5
ER -